rs140076803
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_017807.4(OSGEP):c.328T>C(p.Cys110Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000454 in 1,613,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_017807.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000287 AC: 72AN: 251236Hom.: 0 AF XY: 0.000250 AC XY: 34AN XY: 135774
GnomAD4 exome AF: 0.000463 AC: 676AN: 1461564Hom.: 0 Cov.: 31 AF XY: 0.000455 AC XY: 331AN XY: 727062
GnomAD4 genome AF: 0.000368 AC: 56AN: 152320Hom.: 0 Cov.: 33 AF XY: 0.000376 AC XY: 28AN XY: 74486
ClinVar
Submissions by phenotype
Galloway-Mowat syndrome 3 Pathogenic:5
PS3, PM3, PP3 -
- -
Variant summary: OSGEP c.328T>C (p.Cys110Arg) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00029 in 251236 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in OSGEP causing Galloway-Mowat Syndrome 3, allowing no conclusion about variant significance. c.328T>C has been reported in the literature in individuals affected with Galloway-Mowat Syndrome 3 (e.g. Braun_2017, Baker_2022). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, finding that the variant protein completely failed to rescue cell proliferation in OSGEP knockdown yeast cells (Braun_2017). The following publications have been ascertained in the context of this evaluation (PMID: 28805828, 36063408). ClinVar contains an entry for this variant (Variation ID: 444887). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
not provided Pathogenic:5
- -
This sequence change replaces cysteine, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 110 of the OSGEP protein (p.Cys110Arg). This variant is present in population databases (rs140076803, gnomAD 0.06%). This missense change has been observed in individuals with Galloway-Mowat syndrome (PMID: 28805828). ClinVar contains an entry for this variant (Variation ID: 444887). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt OSGEP protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects OSGEP function (PMID: 28805828). For these reasons, this variant has been classified as Pathogenic. -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28805828, 36587794, 36063408, 36362385, 35783322, 39410922) -
- -
- -
OSGEP-related disorder Pathogenic:1
The OSGEP c.328T>C variant is predicted to result in the amino acid substitution p.Cys110Arg. This variant has been reported in heterozygous state with another pathogenic variant in the OSGEP gene in several patients with Galloway-Mowat syndrome 3 and is considered a founder variant in the European population (Braun et al. 2017. PubMed ID: 28805828; Baker et al. 2022. PubMedID: 36063408). This variant is reported in 0.056% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -
See cases Pathogenic:1
ACMG classification criteria: PS4, PM2, PM3, PP3 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at